Benzinga - Gainers
- Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 66.2% to $0.6312 in pre-market trading after gaining 72% on Wednesday. Minerva Surgical recently announced a $30 million private placement of common stock led by Accelmed Partners.
- American Rebel Holdings, Inc. (NASDAQ: AREB) rose 40% to $0.3290 in pre-market trading after jumping 17% on Wednesday.
- BuzzFeed, Inc. (NASDAQ: BZFD) rose 38.9% to $1.32 in pre-market trading after gaining over 5% on Wednesday. BuzzFeed, last month, reaffirmed its Q4 guidance.
- AppHarvest, Inc. (NASDAQ: APPH) shares rose 27.6% to $2.77 in pre-market trading after gaining around 15% on Tuesday. AppHarvest said on January 11, that it received notice from Nasdaq that the company has not been in compliance with minimum bid price requirement.
- Qualtrics International Inc. (NASDAQ: XM) rose 13.5% to $12.72 in pre-market trading after the company reported better-than-expected fourth-quarter results.
- MicroCloud Hologram Inc. (NASDAQ: HOLO) rose 13.5% to $12.99 in pre-market trading after dropping 8% on Wednesday.
- MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) rose 10.5% to $1.78 in pre-market trading after gaining 11% on Wednesday. Mingzhu, last month, posted 1H revenue of $60.3 million.
- DoubleVerify Holdings, Inc. (NYSE: DV) rose 10% to $27.99 in pre-market trading. DoubleVerify will replace Meridian Bioscience in the S&P SmallCap 600 on Tuesday, Jan. 31.
- Seagate Technology Holdings plc (NASDAQ: STX) shares rose 8.1% to $67.32 in pre-market trading after the company reported better-than-expected Q2 results.
- Tesla, Inc. (NASDAQ: TSLA) rose 6.9% to $154.40 in pre-market trading after the company reported better-than-expected results for its fourth quarter. Vehicle production totaled 439,701 units in the fourth quarter, while deliveries amounted to 405,278 electric vehicles.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) fell 32.4% to $0.83 in pre-market trading after the company announced top-line results from its AR-301-002 Phase 3 study, in which the primary endpoint was not met with statistical significance.
- Magenta Therapeutics, Inc. (NASDAQ: MGTA) shares fell 25.3% to $0.37 in pre-market trading after the company voluntarily paused the MGTA-117 Phase 1/2 dose-escalation clinical trial to investigate drug safety.
- Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell 23.5% to $2.07 in pre-market trading after jumping 8% on Wednesday. Panbela recently announced adoption of commission implementing decision from the EMA for the orphan designation of ivospemin (SBP-101) in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma.
- NeoVolta Inc. (NASDAQ: NEOV) fell 14.7% to $2.30 in pre-market trading. Ageless Dental signed deals for $2.25 billion in property developments over 10 years. Ageless Dental has selected NeoVolta to be included into the design and build of all of their nationwide clinics.
- Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares dropped 8.8% to $1.13 in pre-market trading. Intelligent Bio Solutions recently announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.
- Wolfspeed, Inc. (NYSE: WOLF) fell 8.4% to $75.05 in pre-market trading after the company reported worse-than-expected Q2 sales and issued soft guidance.
- Luokung Technology Corp. (NASDAQ: LKCO) fell 8.3% to $0.21 in pre-market trading after jumping around 24% on Wednesday.
- GeoVax Labs, Inc. (NASDAQ: GOVX) fell 6.3% to $1.04 in pre-market. GeoVax shares gained 59% on Wednesday after the company received a notice of allowance for its zika vaccine patent.
- Millicom International Cellular S.A. (NASDAQ: TIGO) shares fell 6.5% to $17.06 in pre-market trading. Millicom shares jumped 23% on Wednesday following a report suggesting Apollo and Marcelo Claure are exploring a buyout of the company.
- International Business Machines Corporation (NYSE: IBM) fell 2.1% to $137.90 in pre-market trading. IBM reported better-than-expected sales for its fourth quarter on Wednesday. The company plans to reduce around 3,900 jobs that represent 1.5% of its global workforce, reported Bloomberg.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.